Table 1.
Treatment | Samples | ||
---|---|---|---|
Jurkat | SBC-3 | HeLa | |
HuIgG | 9.90 ± 1.6 | 8.80 ± 2.8 | 17.4 ± 4.0 |
Anti-GM2 | 10.0 ± 1.9 | 7.50 ± 2.0 | 16.3 ± 3.8 |
Anti-GM2-sT15 | 10.3 ± 0.1 | 6.50 ± 0.2 | 18.3 ± 4.5 |
Anti-GM2-T15 | 41.3 ± 4.8a | 25.0 ± 8.1a | 25.7 ± 14.0 |
Staurosporine | 99.0 ± 0.1a | 77.7 ± 5.5a | 54.2 ± 12.0a,b |
Data were summarized from three sets of experiments, the percentage of Annexin V positive cells was presented. HuIgG, human IgG; staurosporine (1 nmol/l) was used as an inducer of apoptosis
a P < 0.01 when compared with HuIgG group
bHeLa cells were treated with actinomycin D (1 μg/ml)